PURPOSE: hamstring injury is the most common musculoskeletal disorder and one of the main causes of missed sporting events. Shortening the time to return to play (TTRTP) is a priority for athletes and sports medicine practitioners. HYPOTHESIS: platelet-rich plasma (PRP) injection at the site of severe acute hamstring injury increases the healing rate and shortens the TTRTP. STUDY DESIGN: Cohort study. METHODS: all patients with ultrasonography and MRI evidence of severe acute hamstring injury between January 2012 and March 2014 were offered PRP treatment. Those who accepted received a single intramuscular PRP injection within 8 days post-injury; the other patients served as controls. The same standardized rehabilitation program was used in both groups. A physical examination and ultrasonography were performed 10 and 30 days post-injury, then a phone interview 120 days post-injury, to determine the TTRTP at the pre-injury level. RESULTS: of 34 patients, 15 received PRP and 19 did not. Mean TTRTP at the pre-injury level was 50.9±10.7 days in the PRP group and 52.8±15.7 days in the control group. The difference was not statistically significant. CONCLUSION: a single intramuscular PRP injection did not shorten the TTRTP in sports people with severe acute hamstring injuries.
PURPOSE: hamstring injury is the most common musculoskeletal disorder and one of the main causes of missed sporting events. Shortening the time to return to play (TTRTP) is a priority for athletes and sports medicine practitioners. HYPOTHESIS: platelet-rich plasma (PRP) injection at the site of severe acute hamstring injury increases the healing rate and shortens the TTRTP. STUDY DESIGN: Cohort study. METHODS: all patients with ultrasonography and MRI evidence of severe acute hamstring injury between January 2012 and March 2014 were offered PRP treatment. Those who accepted received a single intramuscular PRP injection within 8 days post-injury; the other patients served as controls. The same standardized rehabilitation program was used in both groups. A physical examination and ultrasonography were performed 10 and 30 days post-injury, then a phone interview 120 days post-injury, to determine the TTRTP at the pre-injury level. RESULTS: of 34 patients, 15 received PRP and 19 did not. Mean TTRTP at the pre-injury level was 50.9±10.7 days in the PRP group and 52.8±15.7 days in the control group. The difference was not statistically significant. CONCLUSION: a single intramuscular PRP injection did not shorten the TTRTP in sports people with severe acute hamstring injuries.
Entities:
Keywords:
hamstring injury; management; muscle injury; platelet-rich plasma (PRP); return to play
Authors: Lauren H Redler; Scott A Thompson; Stephanie H Hsu; Christopher S Ahmad; William N Levine Journal: Phys Sportsmed Date: 2011-02 Impact factor: 2.241
Authors: David M Dohan Ehrenfest; Isabel Andia; Matthias A Zumstein; Chang-Qing Zhang; Nelson R Pinto; Tomasz Bielecki Journal: Muscles Ligaments Tendons J Date: 2014-05-08
Authors: T Hotfiel; R Seil; W Bily; W Bloch; A Gokeler; R M Krifter; F Mayer; P Ueblacker; L Weisskopf; M Engelhardt Journal: J Exp Orthop Date: 2018-06-22